EnteroMedics Eyes First Commercial Maestro Implants For Obesity After Months Of Prep

The company says its training and facility certification efforts are on track to support commercial implants by June. The next challenge will be gaining broad-based reimbursement, as the first procedures are expected to be funded by self-pay or one-off local coverage.

More from Clinical Trials

More from R&D